scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1365-2036.2012.05141.X |
P698 | PubMed publication ID | 22616981 |
P2093 | author name string | N Chande | |
M Levstik | |||
A Sandhu | |||
C H Dale | |||
T Alameel | |||
P433 | issue | 2 | |
P921 | main subject | inflammatory bowel diseases | Q917447 |
P304 | page(s) | 159-165 | |
P577 | publication date | 2012-05-23 | |
P1433 | published in | Alimentary Pharmacology & Therapeutics | Q4726656 |
P1476 | title | The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series | |
P478 | volume | 36 |
Q37354812 | Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes |
Q38496932 | Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease |
Q37682504 | Clinical management of inflammatory bowel disease in the organ recipient |
Q59350071 | Efficacy and Safety of Anti-TNF-α Agents in Inflammatory Bowel Disease After Liver Transplant: A Case Series |
Q38608954 | Evolving strategies to reduce colectomy rates in primary sclerosing cholangitis-inflammatory bowel disease: clinical remission of corticosteroid refractory colitis post-liver transplant with vedolizumab. |
Q42206639 | First case report of de novo ulcerative colitis developing after orthotopic liver transplantation successfully treated by granulocyte and monocyte apheresis |
Q59355703 | Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver |
Q33696372 | Inflammatory bowel disease in liver transplanted patients |
Q38225789 | Management of ulcerative colitis pre- and post-liver transplant for primary sclerosing cholangitis: two case reports and review of literature |
Q88010964 | Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis |
Q35750365 | Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort |
Q101454487 | The Course of Ulcerative Colitis After Pediatric Liver Transplantation for Sclerosing Cholangitis |
Q55291155 | Tumor Necrosis Factor Alpha Inhibition for Inflammatory Bowel Disease after Liver Transplant for Primary Sclerosing Cholangitis. |
Search more.